A Global Perspective on the Adoption of Different Robotic Platforms in Uro-Oncological Surgery
European Urology Focus · 2025-01 · 11 (1) · 22-25
DOI: 10.1016/j.euf.2025.03.016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Urology Focus, 2025-01. Verfasst von Donato Cannoletta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fundació Puigvert, Barcelona, Spain; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San R…. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Urologic Neoplasms, Urologic Surgical Procedures. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Robotic platforms have played a crucial role in minimally invasive surgery, especially for uro-oncological procedures. da Vinci robotic platforms have been the most widely adopted for more than two decades and remain the benchmark worldwide. However, access to robotic platforms varies widely across the globe, mainly because of high costs. More recent platforms, such as the Hugo RAS, KangDuo, and others, are lower-cost alternatives. We provide an overview of the distribution of robotic platforms for uro-oncological surgery across countries on the basis of published evidence. da Vinci robotic platforms remain the most widely adopted, with studies reported from 42 countries, followed by the Hugo RAS in 12 countries. Despite advances, many countries lack data, especially in Africa, South America, and parts of Asia, emphasizing the need for multidisciplinary collaboration, training, and policy initiatives. Recently approved novel platforms may contribute to expansion of access to robotic surgery in underserved regions. PATIENT SUMMARY: We reviewed the use of robotic systems for surgery for urological cancers around the globe. We found that the da Vinci system is the most widely used worldwide, but there is a gap in access to these robots in Africa, South America, and parts of Asia. New platforms that are less expensive could lead to wider use of robotic surgery in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Fundació Puigvert, Barcelona, Spain; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Ita…
- Department of Urology, Fundació Puigvert, Barcelona, Spain.
- Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
- Department of Urology, Fundació Puigvert, Barcelona, Spain; Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.
- Department of Urology, Fundació Puigvert, Barcelona, Spain; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.
Zitieren
APA
Cannoletta, D., Gallioli, A., Mazzone, E., Gaya Sopena, J. M., Territo, A., Bello, F. D., Casadevall, M., Mas, L., Mancon, S., Diana, P., Palou, J., & Breda, A. (2025). A Global Perspective on the Adoption of Different Robotic Platforms in Uro-Oncological Surgery. European Urology Focus, 11(1), 22-25. https://doi.org/10.1016/j.euf.2025.03.016
Vancouver
Cannoletta D, Gallioli A, Mazzone E, Gaya Sopena JM, Territo A, Bello FD, et al. A Global Perspective on the Adoption of Different Robotic Platforms in Uro-Oncological Surgery. European Urology Focus. 2025;11(1):22-25. doi:10.1016/j.euf.2025.03.016
BibTeX
@article{Cannoletta2025,
author = {Cannoletta, Donato and Gallioli, Andrea and Mazzone, Elio and Gaya Sopena, Josep Maria and Territo, Angelo and Bello, Francesco Di and Casadevall, Marta and Mas, Laura and Mancon, Stefano and Diana, Pietro and Palou, Joan and Breda, Alberto},
title = {A Global Perspective on the Adoption of Different Robotic Platforms in Uro-Oncological Surgery},
journal = {European Urology Focus},
year = {2025},
volume = {11},
number = {1},
pages = {22--25},
doi = {10.1016/j.euf.2025.03.016}
}
EUVIMED